{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:50:21Z","timestamp":1770720621157,"version":"3.49.0"},"publisher-location":"Berlin, Heidelberg","reference-count":39,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540736769","type":"print"},{"value":"9783540736776","type":"electronic"}],"license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008]]},"DOI":"10.1007\/978-3-540-73677-6_14","type":"book-chapter","created":{"date-parts":[[2007,12,23]],"date-time":"2007-12-23T20:38:17Z","timestamp":1198442297000},"page":"343-356","source":"Crossref","is-referenced-by-count":16,"title":["Neuromyelitis Optica: Clinical Syndrome and the NMO-IgG Autoantibody Marker"],"prefix":"10.1007","author":[{"given":"B. G.","family":"Weinshenker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. M.","family":"Wingerchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1_Ref","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0014-5793(03)01083-4","volume":"555","author":"P Agre","year":"2003","unstructured":"Agre P, Kozono D (2003) Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett 555:72-78","journal-title":"FEBS Lett"},{"key":"14_CR2_Ref","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0140-6736(02)68218-2","volume":"1","author":"TC Albutt","year":"1870","unstructured":"Albutt TC (1870) On the ophthalmoscopic signs of spinal disease. Lancet 1:76-78","journal-title":"Lancet"},{"key":"14_CR3_Ref","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nrn1252","volume":"4","author":"M Amiry-Moghaddam","year":"2003","unstructured":"Amiry-Moghaddam M, Ottersen OP (2003) The molecular basis of water transport in the brain. Nat Rev Neurosci 4:991-1001","journal-title":"Nat Rev Neurosci"},{"key":"14_CR4_Ref","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","volume":"64","author":"BA Cree","year":"2005","unstructured":"Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270-1272","journal-title":"Neurology"},{"key":"14_CR5_Ref","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1191\/1352458503ms947oa","volume":"9","author":"J de Seze","year":"2003","unstructured":"de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chatel M, Vermersch P (2003) Is Devic\u2019s neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 9:521-525","journal-title":"Mult Scler"},{"key":"14_CR6_Ref","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0022-510X(02)00043-6","volume":"197","author":"J de Seze","year":"2002","unstructured":"de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F, Verier A, Pruvo JP, Hache JC, Vermersch P (2002) Devic\u2019s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197:57-61","journal-title":"J Neurol Sci"},{"key":"14_CR7_Ref","first-page":"1033","volume":"8","author":"E Devic","year":"1894","unstructured":"Devic E (1894) My\u00e9lite aigue compliqu\u00e9e de n\u00e9vrite optique. Bull Med (Paris) 8:1033-1034","journal-title":"Bull Med (Paris)"},{"key":"14_CR8_Ref","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","volume":"251","author":"A Ghezzi","year":"2004","unstructured":"Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G (2004) Clinical characteristics, course and prognosis of relapsing Devic\u2019s neuromyelitis optica. J Neurol 251:47-52","journal-title":"J Neurol"},{"key":"14_CR9_Ref","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","volume":"68","author":"S Jarius","year":"2007","unstructured":"Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, Hohlfeld R, Vincent A (2007) NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68:1076-1077","journal-title":"Neurology"},{"key":"14_CR10_Ref","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","volume":"366","author":"M Keegan","year":"2005","unstructured":"Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579-582","journal-title":"Lancet"},{"key":"14_CR11_Ref","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","volume":"58","author":"M Keegan","year":"2002","unstructured":"Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58:143-146","journal-title":"Neurology"},{"key":"14_CR12_Ref","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","volume":"2","author":"J Kira","year":"2003","unstructured":"Kira J (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2:117-127","journal-title":"Lancet Neurol"},{"key":"14_CR13_Ref","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archneur.63.6.851","volume":"63","author":"I Kister","year":"2006","unstructured":"Kister I, Gulati S, Boz C, Bergamaschi R, Piccolo G, Oger J, Swerdlow ML (2006) Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 63:851-856","journal-title":"Arch Neurol"},{"key":"14_CR14_Ref","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1471-4914(00)01909-2","volume":"7","author":"H Lassmann","year":"2001","unstructured":"Lassmann H, Bruck W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7:115-121","journal-title":"Trends Mol Med"},{"key":"14_CR15_Ref","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473-477","journal-title":"J Exp Med"},{"key":"14_CR16_Ref","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106-2112","journal-title":"Lancet"},{"key":"14_CR17_Ref","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125:1450-1461","journal-title":"Brain"},{"key":"14_CR18_Ref","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","volume":"51","author":"RN Mandler","year":"1998","unstructured":"Mandler RN, Ahmed W, Dencoff JE (1998) Devic\u2019s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 51:1219-1220","journal-title":"Neurology"},{"key":"14_CR19_Ref","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1620\/tjem.209.269","volume":"209","author":"T Misu","year":"2006","unstructured":"Misu T, Fujihara K, Nakamura M, Murakami K, Endo M, Konno H, Itoyama Y (2006) Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 209:269-275","journal-title":"Tohoku J Exp Med"},{"key":"14_CR20_Ref","first-page":"A39","volume":"64","author":"T Misu","year":"2005","unstructured":"Misu T, Kakita A, Fujihara K et al (2005) A comparative neuropathological analysis of Japanese cases of neuromyelitis optica and multiple sclerosis. Neurology 64:A39","journal-title":"Neurology"},{"key":"14_CR21_Ref","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/jnnp.2005.080390","volume":"77","author":"I Nakashima","year":"2006","unstructured":"Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y, Sato S, Weinshenker BG, Itoyama Y (2006) Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77:1073-1075","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR22_Ref","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","volume":"17","author":"S Nielsen","year":"1997","unstructured":"Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP (1997) Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 17:171-180","journal-title":"J Neurosci"},{"key":"14_CR23_Ref","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/jnnp.60.4.382","volume":"60","author":"JI O\u2019Riordan","year":"1996","unstructured":"O\u2019Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, McDonald WI, Miller DH (1996) Clinical, CSF, and MRI findings in Devic\u2019s neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382-387","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR24_Ref","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/jnnp.73.4.429","volume":"73","author":"RM Papais-Alvarenga","year":"2002","unstructured":"Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, de Almeida AM, Oliveira S, Basilio De Oliveira CA, Alvarenga H, Poser CM (2002) Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 73:429-435","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"[Suppl1]","key":"14_CR25_Ref","first-page":"A328","volume":"64","author":"C Papeix","year":"2005","unstructured":"Papeix C, de Seze J (2005) French therapeutic experience of Devic\u2019s disease: a retrospective study of 33 cases. Neurology 64 [Suppl1]:A328-A329","journal-title":"Neurology"},{"key":"14_CR26_Ref","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/WNL.62.4.601","volume":"62","author":"SJ Pittock","year":"2004","unstructured":"Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M (2004) Disability profile of MS did not change over 10 years in a populationbased prevalence cohort. Neurology 62:601-606","journal-title":"Neurology"},{"key":"14_CR27_Ref","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archneur.63.3.390","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63:390-396","journal-title":"Arch Neurol"},{"key":"14_CR28_Ref","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63:964-968","journal-title":"Arch Neurol"},{"key":"14_CR29_Ref","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1191\/1352458505ms1200cr","volume":"11","author":"AY Poppe","year":"2005","unstructured":"Poppe AY, Lapierre Y, Melancon D, Lowden D, Wardell L, Fullerton LM, Bar-Or A (2005) Neuromyelitis optica with hypothalamic involvement. Mult Scler 11:617-621","journal-title":"Mult Scler"},{"key":"14_CR30_Ref","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130:1194-1205","journal-title":"Brain"},{"key":"14_CR31_Ref","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jns.2006.10.008","volume":"252","author":"Y Warabi","year":"2006","unstructured":"Warabi Y, Matsumoto Y, Hayashi H (2006) Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 252:57-61","journal-title":"J Neurol Sci"},{"key":"14_CR32_Ref","first-page":"S16","volume":"12","author":"B Weinshenker","year":"2006","unstructured":"Weinshenker B, Pittock S, de Seze J, Vermersch P, Wingerchuk D, Zephir H, Homberger H, Lucchinetti C, Lennon V (2006) The relationship between neuromyelitis optica and systemic autoimmune disease. Mult Scler 12:S16","journal-title":"Mult Scler"},{"key":"14_CR33_Ref","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","volume":"46","author":"BG Weinshenker","year":"1999","unstructured":"Weinshenker BG, O\u2019Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878-886","journal-title":"Ann Neurol"},{"key":"14_CR34_Ref","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.20770","volume":"59","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566-569","journal-title":"Ann Neurol"},{"key":"14_CR35_Ref","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archneur.63.7.957","volume":"63","author":"B Weinstock-Guttman","year":"2006","unstructured":"Weinstock-Guttman B, Ramanathan M, Lincoff N, Napoli SQ, Sharma J, Feichter J, Bakshi R (2006) Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 63:957-963","journal-title":"Arch Neurol"},{"key":"14_CR36_Ref","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53:1107-1114","journal-title":"Neurology"},{"key":"14_CR37_Ref","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485-1489","journal-title":"Neurology"},{"key":"14_CR38_Ref","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11940-005-0010-6","volume":"7","author":"DM Wingerchuk","year":"2005","unstructured":"Wingerchuk DM, Weinshenker BG (2005) Neuromyelitis optica. Curr Treat Options Neurol 7:173-182","journal-title":"Curr Treat Options Neurol"},{"key":"14_CR39_Ref","first-page":"314","volume":"21","author":"L Zuliani","year":"2006","unstructured":"Zuliani L, Lopez de Munain A, Ruiz Martinez J, Olascoaga J, Graus F, Saiz A (2006) Anticuerpos IgG-NMO en la neuromyelitis optica: proposito de 2 casos. Neurologia 21:314-317","journal-title":"Neurologia"}],"container-title":["Current Topics in Microbiology and Immunology","Advances in multiple Sclerosis and Experimental Demyelinating Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-73677-6_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T10:54:10Z","timestamp":1558090450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-73677-6_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"ISBN":["9783540736769","9783540736776"],"references-count":39,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-73677-6_14","relation":{},"ISSN":["0070-217X"],"issn-type":[{"value":"0070-217X","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}